US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CG Oncology Inc.

39.82

-0.0350-0.09%

Post-market: 39.820.00000.00%19:30 EDT

Volume:560.51K

Turnover:22.29M

Market Cap:3.04B

PE:-22.44

High:40.27

Open:40.19

Low:39.15

Close:39.86

52wk High:40.65

52wk Low:14.80

Shares:76.25M

Float Shares:61.28M

Volume Ratio:0.62

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7747

EPS(LYR):-1.4087

ROE:-16.57%

ROA:-12.85%

PB:4.53

PE(LYR):-28.27

Loading ...

Overview Company News Filings

Analysts Offer Insights on NA Companies: Rubrik, Inc. Class A (RBRK) and CG Oncology, Inc. (CGON)

CG Oncology Director Leonard E. Post Reports Disposal of Common Shares

CG Oncology Director James Mulay Reports Disposal of Common Shares

CG Oncology Is Maintained at Overweight by JP Morgan

CG Oncology Inc : JP Morgan Raises Target Price to $47 From $41

THOMSON REUTERS

Director James Mulay Reports Disposal of Common Shares of CG Oncology Inc

CG Oncology (CGON) Is Up 10.7% After Positive Phase 3 Results and Insider Buying – What's Changed

Simply Wall St.

CG Oncology, Inc. (CGON) Gets a Buy from LifeSci Capital

CG Oncology Is Maintained at Overweight by Morgan Stanley

CG Oncology price target raised to $79 from $56 at Morgan Stanley

Analysts Are Bullish on Top NA Stocks: CG Oncology, Inc. (CGON), Rubrik, Inc. Class A (RBRK)

Citizens JMP healthcare analysts hold an analyst/industry conference call

Massive Investment Alert: CG Oncology’s Director Makes a Bold Move!

Director Brian Guan-Chyun Liu Reports Acquisition of Common Shares in CG Oncology Inc

CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

LifeSci Capital Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)

CG Oncology Price Target Maintained With a $75.00/Share by Cantor Fitzgerald

CG Oncology Stock Signals Bullish Momentum Ahead

Benzinga_recent_news

JonesTrading Initiates CG Oncology at Buy With $50 Price Target

MT Newswires Live

CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CGON/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":39.82,"timestamp":1759521600000,"preClose":39.855,"halted":0,"volume":560505,"hourTrading":{"tag":"盘后","latestPrice":39.82,"preClose":39.82,"latestTime":"19:30 EDT","volume":12372,"amount":492669.25,"timestamp":1759534205050},"delay":0,"floatShares":61279875,"shares":76247581,"eps":-1.774667,"marketStatus":"Market Closed","change":-0.035,"latestTime":"10-03 16:00:00 EDT","open":40.19,"high":40.265,"low":39.15,"amount":22287870.37455,"amplitude":0.027976,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.774667,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1759737600000},"marketStatusCode":7,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":39.855,"preHourTrading":{"tag":"盘前","latestPrice":40.15,"preClose":39.855,"latestTime":"08:40 EDT","volume":179,"amount":7134.780332,"timestamp":1759495217816},"postHourTrading":{"tag":"盘后","latestPrice":39.82,"preClose":39.82,"latestTime":"19:30 EDT","volume":12372,"amount":492669.25,"timestamp":1759534205050},"volumeRatio":0.6206345586483574,"impliedVol":0.2179,"impliedVolPercentile":0.036},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","floatShares":61279875,"roa":"-12.85%","roe":"-16.57%","lyrEps":-1.408697,"volumeRatio":0.6206345586483574,"shares":76247581,"dividePrice":0,"high":40.265,"amplitude":0.027976,"preClose":39.855,"low":39.15,"week52Low":14.8,"pbRate":"4.53","psRate":"5510.31","week52High":40.65,"institutionHeld":0,"latestPrice":39.82,"eps":-1.774667,"divideRate":0,"volume":560505,"delay":0,"ttmEps":-1.774667,"open":40.19,"prevYearClose":28.68,"prevWeekClose":37.54,"prevMonthClose":40.28,"prevQuarterClose":40.28,"fiveDayClose":37.54,"twentyDayClose":33.07,"sixtyDayClose":27.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-08","symbol":"CGON","fiscalQuarterEnding":"2025/06","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2025-05-13","symbol":"CGON","fiscalQuarterEnding":"2025/03","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-03-28","symbol":"CGON","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2024-11-12","symbol":"CGON","fiscalQuarterEnding":"2024/09","expectedEps":-0.42,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0833,"buy":0.9167,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.9167,"analysts":12,"updateTime":1757390400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGON","date":"2025-10-03","current":-22.438012,"percent":0.693827,"low":-77.942097,"twenty":-44.665332,"median":-31.426132,"eighty":-19.253545,"high":-13.496527,"avg":-34.698188,"sd":15.289123,"marketCap":3038847340},"quantilePoints":[{"date":"2024-01-26","current":-62.124194,"twenty":-62.124194,"median":-62.124194,"eighty":-62.124194,"marketCap":2539823423},{"date":"2024-02-02","current":-61.712969,"twenty":-61.712969,"median":-60.379514,"eighty":-59.355029,"marketCap":2523011292},{"date":"2024-02-09","current":-63.452965,"twenty":-62.124194,"median":-60.590915,"eighty":-59.355029,"marketCap":2594147579},{"date":"2024-02-16","current":-77.177799,"twenty":-70.608092,"median":-61.918582,"eighty":-60.168112,"marketCap":3155259972},{"date":"2024-02-23","current":-75.080046,"twenty":-72.448911,"median":-64.672589,"eighty":-60.20714,"marketCap":3069497532},{"date":"2024-03-01","current":-72.705845,"twenty":-73.870179,"median":-70.608092,"eighty":-60.516111,"marketCap":2972433066},{"date":"2024-03-08","current":-64.818944,"twenty":-72.891228,"median":-69.827533,"eighty":-60.799064,"marketCap":2649992888},{"date":"2024-03-15","current":-60.493345,"twenty":-72.302556,"median":-67.469593,"eighty":-60.20714,"marketCap":2473149409},{"date":"2024-03-22","current":-66.867912,"twenty":-72.162706,"median":-65.355579,"eighty":-60.438055,"marketCap":2733760852},{"date":"2024-03-28","current":-56.207672,"twenty":-71.967566,"median":-64.762028,"eighty":-59.842879,"marketCap":2732086332},{"date":"2024-04-05","current":-51.752186,"twenty":-71.648838,"median":-63.50175,"eighty":-58.14191,"marketCap":2515518513},{"date":"2024-04-12","current":-54.631116,"twenty":-71.284577,"median":-62.382039,"eighty":-56.136384,"marketCap":2655454642},{"date":"2024-04-19","current":-48.420853,"twenty":-71.001624,"median":-61.712969,"eighty":-54.576279,"marketCap":2353592420},{"date":"2024-04-26","current":-49.627262,"twenty":-70.73168,"median":-60.54213,"eighty":-53.208102,"marketCap":2412232322},{"date":"2024-05-03","current":-54.151294,"twenty":-70.286112,"median":-60.183337,"eighty":-53.600185,"marketCap":2632131954},{"date":"2024-05-10","current":-35.176138,"twenty":-69.778748,"median":-59.371617,"eighty":-52.278619,"marketCap":2000537303},{"date":"2024-05-17","current":-36.289307,"twenty":-68.393255,"median":-58.232975,"eighty":-49.860318,"marketCap":2063845445},{"date":"2024-05-24","current":-35.140985,"twenty":-67.52163,"median":-57.330453,"eighty":-49.032283,"marketCap":1998538098},{"date":"2024-05-31","current":-40.179539,"twenty":-67.228921,"median":-56.207672,"eighty":-47.173317,"marketCap":2285090743},{"date":"2024-06-07","current":-40.894311,"twenty":-66.477632,"median":-55.878652,"eighty":-42.192617,"marketCap":2325741235},{"date":"2024-06-14","current":-40.788853,"twenty":-65.885708,"median":-55.522213,"eighty":-41.278647,"marketCap":2319743621},{"date":"2024-06-21","current":-37.625109,"twenty":-65.85969,"median":-54.631116,"eighty":-40.788853,"marketCap":2139815216},{"date":"2024-06-28","current":-35.445642,"twenty":-65.443392,"median":-54.494024,"eighty":-40.683395,"marketCap":2015864537},{"date":"2024-07-05","current":-36.125261,"twenty":-64.796178,"median":-54.151294,"eighty":-39.560851,"marketCap":2054515824},{"date":"2024-07-12","current":-40.378738,"twenty":-64.675841,"median":-53.136814,"eighty":-38.206301,"marketCap":2296419569},{"date":"2024-07-15","current":-41.491907,"twenty":-64.64657,"median":-52.780375,"eighty":-38.236766,"marketCap":2359727711},{"date":"2024-08-02","current":-39.652248,"twenty":-64.6173,"median":-52.752957,"eighty":-38.267232,"marketCap":2255102676},{"date":"2024-08-09","current":-38.949194,"twenty":-63.924553,"median":-51.752186,"eighty":-38.000071,"marketCap":2215118586},{"date":"2024-08-16","current":-40.572681,"twenty":-63.472479,"median":-49.956283,"eighty":-38.105529,"marketCap":2307449488},{"date":"2024-08-23","current":-42.377221,"twenty":-62.965116,"median":-49.723226,"eighty":-38.189896,"marketCap":2410077328},{"date":"2024-08-30","current":-43.2618,"twenty":-62.33047,"median":-48.934948,"eighty":-38.276606,"marketCap":2460385093},{"date":"2024-09-06","current":-44.299706,"twenty":-62.063778,"median":-48.270052,"eighty":-38.375033,"marketCap":2519412871},{"date":"2024-09-13","current":-41.079839,"twenty":-61.869081,"median":-45.980618,"eighty":-38.588613,"marketCap":2336292606},{"date":"2024-09-20","current":-46.127835,"twenty":-61.368222,"median":-44.806865,"eighty":-38.861791,"marketCap":2623382252},{"date":"2024-09-27","current":-43.379744,"twenty":-60.747027,"median":-44.736098,"eighty":-39.046612,"marketCap":2467092795},{"date":"2024-10-04","current":-42.412604,"twenty":-60.551887,"median":-44.517902,"eighty":-39.324835,"marketCap":2412089639},{"date":"2024-10-11","current":-40.667036,"twenty":-60.382766,"median":-44.458898,"eighty":-39.52313,"marketCap":2312815649},{"date":"2024-10-18","current":-43.356155,"twenty":-60.203473,"median":-44.063818,"eighty":-39.574912,"marketCap":2465751255},{"date":"2024-10-25","current":-42.990529,"twenty":-60.177247,"median":-43.698192,"eighty":-39.657154,"marketCap":2444957379},{"date":"2024-10-31","current":-42.837202,"twenty":-60.01213,"median":-43.662809,"eighty":-39.673778,"marketCap":2436237366},{"date":"2024-11-08","current":-46.068863,"twenty":-59.381569,"median":-43.651015,"eighty":-39.804577,"marketCap":2620028401},{"date":"2024-11-15","current":-32.980568,"twenty":-59.208121,"median":-43.63922,"eighty":-39.654701,"marketCap":2400853462},{"date":"2024-11-22","current":-30.044833,"twenty":-58.542987,"median":-43.538968,"eighty":-38.997903,"marketCap":2187143689},{"date":"2024-11-29","current":-32.283796,"twenty":-58.232975,"median":-43.444613,"eighty":-38.328163,"marketCap":2350131206},{"date":"2024-12-06","current":-31.17825,"twenty":-58.005312,"median":-43.379744,"eighty":-38.000071,"marketCap":2269651893},{"date":"2024-12-13","current":-26.821099,"twenty":-57.745125,"median":-43.279491,"eighty":-37.543086,"marketCap":1952468717},{"date":"2024-12-20","current":-26.031423,"twenty":-56.915781,"median":-43.120267,"eighty":-36.394765,"marketCap":1894983493},{"date":"2024-12-27","current":-27.044066,"twenty":-56.349294,"median":-43.061296,"eighty":-36.125261,"marketCap":1968699839},{"date":"2025-01-03","current":-26.914002,"twenty":-56.207672,"median":-43.037707,"eighty":-35.33784,"marketCap":1959231684},{"date":"2025-01-10","current":-28.298257,"twenty":-56.136384,"median":-42.978735,"eighty":-34.953504,"marketCap":2059999900},{"date":"2025-01-17","current":-27.034776,"twenty":-55.969133,"median":-42.872585,"eighty":-33.374909,"marketCap":1968023542},{"date":"2025-01-24","current":-32.158189,"twenty":-55.840266,"median":-42.689773,"eighty":-32.852839,"marketCap":2340987506},{"date":"2025-01-31","current":-31.530712,"twenty":-55.653821,"median":-42.565931,"eighty":-32.283796,"marketCap":2295309701},{"date":"2025-02-07","current":-31.405216,"twenty":-55.437216,"median":-42.394913,"eighty":-32.036945,"marketCap":2286174140},{"date":"2025-02-14","current":-29.805151,"twenty":-55.004006,"median":-42.206678,"eighty":-31.677123,"marketCap":2169695737},{"date":"2025-02-21","current":-29.512328,"twenty":-54.631116,"median":-41.999801,"eighty":-31.530712,"marketCap":2148379428},{"date":"2025-02-28","current":-25.768383,"twenty":-54.494024,"median":-41.775708,"eighty":-31.373843,"marketCap":1875835192},{"date":"2025-03-07","current":-28.226,"twenty":-54.39406,"median":-41.609082,"eighty":-31.094637,"marketCap":2054739928},{"date":"2025-03-14","current":-27.138374,"twenty":-54.151294,"median":-41.292708,"eighty":-30.560445,"marketCap":1975565066},{"date":"2025-03-21","current":-29.020804,"twenty":-53.671473,"median":-41.068045,"eighty":-30.21301,"marketCap":2112598481},{"date":"2025-03-28","current":-28.173711,"twenty":-53.493253,"median":-40.922206,"eighty":-29.826066,"marketCap":2050933444},{"date":"2025-04-04","current":-16.223536,"twenty":-52.780375,"median":-40.788853,"eighty":-29.478125,"marketCap":1428303862},{"date":"2025-04-11","current":-15.26259,"twenty":-52.725539,"median":-40.592885,"eighty":-29.073094,"marketCap":1343703153},{"date":"2025-04-17","current":-17.504797,"twenty":-52.648767,"median":-40.36956,"eighty":-28.807616,"marketCap":1541104808},{"date":"2025-04-25","current":-18.630229,"twenty":-51.927664,"median":-39.710836,"eighty":-28.715432,"marketCap":1640186719},{"date":"2025-05-02","current":-24.014988,"twenty":-51.631545,"median":-39.587801,"eighty":-28.276198,"marketCap":2114255557},{"date":"2025-05-09","current":-20.891121,"twenty":-50.318205,"median":-39.192738,"eighty":-28.046644,"marketCap":1839233409},{"date":"2025-05-16","current":-18.305859,"twenty":-49.931606,"median":-38.624431,"eighty":-27.822323,"marketCap":1932311557},{"date":"2025-05-23","current":-18.60193,"twenty":-49.805481,"median":-38.19927,"eighty":-27.481395,"marketCap":1963563934},{"date":"2025-05-30","current":-18.941329,"twenty":-49.745161,"median":-38.000071,"eighty":-27.137812,"marketCap":1999389828},{"date":"2025-06-06","current":-19.230179,"twenty":-49.665648,"median":-37.795014,"eighty":-26.986466,"marketCap":2029879952},{"date":"2025-06-13","current":-19.136302,"twenty":-49.503879,"median":-37.543086,"eighty":-26.644583,"marketCap":2019970662},{"date":"2025-06-20","current":-18.977435,"twenty":-49.032283,"median":-37.168124,"eighty":-26.449487,"marketCap":2003201094},{"date":"2025-06-27","current":-18.825789,"twenty":-48.437304,"median":-36.365471,"eighty":-26.243173,"marketCap":1987193779},{"date":"2025-07-03","current":-19.425152,"twenty":-48.360533,"median":-36.207284,"eighty":-25.994262,"marketCap":2050460785},{"date":"2025-07-11","current":-19.576798,"twenty":-47.916755,"median":-36.101826,"eighty":-24.54782,"marketCap":2066468099},{"date":"2025-07-18","current":-20.551667,"twenty":-47.047797,"median":-35.158562,"eighty":-23.322415,"marketCap":2169372265},{"date":"2025-07-25","current":-18.876337,"twenty":-46.758067,"median":-34.836328,"eighty":-20.953178,"marketCap":1992529551},{"date":"2025-08-01","current":-19.273506,"twenty":-46.459723,"median":-33.67043,"eighty":-19.630235,"marketCap":2034453470},{"date":"2025-08-08","current":-17.583734,"twenty":-46.116041,"median":-33.231407,"eighty":-19.436706,"marketCap":1856086249},{"date":"2025-08-15","current":-15.454183,"twenty":-46.05471,"median":-32.738157,"eighty":-19.425152,"marketCap":1979387202},{"date":"2025-08-22","current":-15.466089,"twenty":-45.994601,"median":-32.283796,"eighty":-19.321744,"marketCap":1980912154},{"date":"2025-08-29","current":-15.90364,"twenty":-45.910989,"median":-32.179105,"eighty":-19.234852,"marketCap":2036954126},{"date":"2025-09-05","current":-18.418814,"twenty":-45.632471,"median":-32.073773,"eighty":-19.17963,"marketCap":2359100156},{"date":"2025-09-12","current":-19.740397,"twenty":-45.219668,"median":-31.708497,"eighty":-19.194072,"marketCap":2528369785},{"date":"2025-09-19","current":-23.109837,"twenty":-44.877631,"median":-31.635292,"eighty":-19.201294,"marketCap":2959931094},{"date":"2025-09-26","current":-21.716818,"twenty":-44.736098,"median":-31.530712,"eighty":-19.230179,"marketCap":2781511754},{"date":"2025-10-03","current":-23.725981,"twenty":-44.665332,"median":-31.426132,"eighty":-19.253545,"marketCap":3038847340}],"updateTime":1759699360889},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGON\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2572514135","title":"Analysts Offer Insights on NA Companies: Rubrik, Inc. Class A (RBRK) and CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572514135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572514135?lang=en_us&edition=fundamental","pubTime":"2025-10-02 20:00","pubTimestamp":1759406427,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Rubrik, Inc. Class A (RBRK – Research Report) and CG Oncolog...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rubrik-inc-class-a-rbrk-and-cg-oncology-inc-cgon-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rubrik-inc-class-a-rbrk-and-cg-oncology-inc-cgon-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","BK4141","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NA","LU2286300806.USD","BK4097","BK4139","BK4613","IE00B64PRP62.GBP","RBRK","BK4135","CGON"],"gpt_icon":0},{"id":"2572382568","title":"CG Oncology Director Leonard E. Post Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2572382568","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572382568?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:07","pubTimestamp":1759352878,"startTime":"0","endTime":"0","summary":"Leonard E. Post, Director, reported a disposal of common shares of CG Oncology Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDLbhSTzh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2572746053","title":"CG Oncology Director James Mulay Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2572746053","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572746053?lang=en_us&edition=fundamental","pubTime":"2025-10-01 04:40","pubTimestamp":1759264801,"startTime":"0","endTime":"0","summary":"James Mulay, Director at CG Oncology Inc., reported a disposal of common shares of CG Oncology Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDLn1rH0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2570888128","title":"CG Oncology Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2570888128","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570888128?lang=en_us&edition=fundamental","pubTime":"2025-09-26 19:57","pubTimestamp":1758887820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 26, 2025 07:57 ET (11:57 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2570300529","title":"CG Oncology Inc : JP Morgan Raises Target Price to $47 From $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2570300529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570300529?lang=en_us&edition=fundamental","pubTime":"2025-09-26 17:07","pubTimestamp":1758877633,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nFWN3VD0FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2569711252","title":"Director James Mulay Reports Disposal of Common Shares of CG Oncology Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2569711252","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569711252?lang=en_us&edition=fundamental","pubTime":"2025-09-23 23:38","pubTimestamp":1758641923,"startTime":"0","endTime":"0","summary":"James Mulay, a Director at CG Oncology Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 22, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL54X3vW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2569276866","title":"CG Oncology (CGON) Is Up 10.7% After Positive Phase 3 Results and Insider Buying – What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2569276866","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569276866?lang=en_us&edition=fundamental","pubTime":"2025-09-22 03:47","pubTimestamp":1758484055,"startTime":"0","endTime":"0","summary":"Recent updates from CG Oncology highlighted positive results from its Phase 3 BOND-003 Cohort C study, with a 41.8% complete response rate at 24 months for its bladder cancer treatment, cretostimogene.\nA significant insider purchase by Director Brian Guan-Chyun Liu added further momentum, signaling internal confidence as analysts noted the therapy’s durable outcomes.\nWe’ll explore how the strong Phase 3 results for cretostimogene reinforce CG Oncology’s investment narrative in cancer...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-is-up-107-after-positive-phase-3-results-an","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-is-up-107-after-positive-phase-3-results-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CG","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139","IE00B64PRP62.GBP","BK4135","CGON"],"gpt_icon":0},{"id":"2569223608","title":"CG Oncology, Inc. (CGON) Gets a Buy from LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2569223608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569223608?lang=en_us&edition=fundamental","pubTime":"2025-09-21 16:15","pubTimestamp":1758442509,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Buy rating on CG Oncology, Inc. yesterday and set a price target of $90.00. The company’s shares c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-gets-a-buy-from-lifesci-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-gets-a-buy-from-lifesci-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64PRP62.GBP","CG","IE00BGHQF748.EUR","CGON","BK4139","IE00B3QW5Z07.USD","BK4135"],"gpt_icon":0},{"id":"2568416871","title":"CG Oncology Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2568416871","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568416871?lang=en_us&edition=fundamental","pubTime":"2025-09-18 02:10","pubTimestamp":1758132600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 17, 2025 14:10 ET (18:10 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2568467508","title":"CG Oncology price target raised to $79 from $56 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2568467508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568467508?lang=en_us&edition=fundamental","pubTime":"2025-09-17 18:10","pubTimestamp":1758103815,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on CG Oncology (CGON) to $79 from $56 and keeps an Overweight rating on the shares. The approval of I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-79-from-56-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-price-target-raised-to-79-from-56-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2568632594","title":"Analysts Are Bullish on Top NA Stocks: CG Oncology, Inc. (CGON), Rubrik, Inc. Class A (RBRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568632594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568632594?lang=en_us&edition=fundamental","pubTime":"2025-09-17 15:20","pubTimestamp":1758093611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on CG Oncology, Inc. (CGON – Research Report) and Rubrik, Inc. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-cg-oncology-inc-cgon-rubrik-inc-class-a-rbrk-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-cg-oncology-inc-cgon-rubrik-inc-class-a-rbrk-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NA","CG","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2286300806.USD","RBRK","BK4112","BK4097","BK4613","BK4135","IE00BGHQF748.EUR","CGON","BK4141","BK4139"],"gpt_icon":0},{"id":"2568448092","title":"Citizens JMP healthcare analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2568448092","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568448092?lang=en_us&edition=fundamental","pubTime":"2025-09-17 02:41","pubTimestamp":1758048102,"startTime":"0","endTime":"0","summary":"Healthcare Analysts discuss the emerging treatment options for high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) (relevant companies ENGN CGON J...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citizens-jmp-healthcare-analysts-hold-an-analyst-industry-conference-call-thefly-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citizens-jmp-healthcare-analysts-hold-an-analyst-industry-conference-call-thefly-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGON","JMP","BK4127"],"gpt_icon":0},{"id":"2567794122","title":"Massive Investment Alert: CG Oncology’s Director Makes a Bold Move!","url":"https://stock-news.laohu8.com/highlight/detail?id=2567794122","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567794122?lang=en_us&edition=fundamental","pubTime":"2025-09-16 10:07","pubTimestamp":1757988468,"startTime":"0","endTime":"0","summary":"New insider activity at CG Oncology, Inc. ( ($CGON) ) has taken place on September 15, 2025. Director Brian Guan-Chyun Liu has made a significant i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/massive-investment-alert-cg-oncologys-director-makes-a-bold-move-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/massive-investment-alert-cg-oncologys-director-makes-a-bold-move-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BGHQF748.EUR","BK4135","CGON","CG","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4139"],"gpt_icon":0},{"id":"2567111769","title":"Director Brian Guan-Chyun Liu Reports Acquisition of Common Shares in CG Oncology Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2567111769","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567111769?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:32","pubTimestamp":1757939576,"startTime":"0","endTime":"0","summary":"Brian Guan-Chyun Liu, a director and the beneficial owner, reported an acquisition of common shares of CG Oncology Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL8q2YKg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Brian Guan-Chyun Liu Reports Acquisition of Common Shares in CG Oncology Inc","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2567119140","title":"CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2567119140","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567119140?lang=en_us&edition=fundamental","pubTime":"2025-09-15 19:59","pubTimestamp":1757937540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 15, 2025 07:59 ET (11:59 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2567539115","title":"LifeSci Capital Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567539115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567539115?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:55","pubTimestamp":1757933726,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on CG Oncology, Inc., with a price target of $90.00. The compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-buy-rating-on-cg-oncology-inc-cgon-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-buy-rating-on-cg-oncology-inc-cgon-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"gpt_icon":0},{"id":"2565682467","title":"CG Oncology Price Target Maintained With a $75.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2565682467","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565682467?lang=en_us&edition=fundamental","pubTime":"2025-09-08 21:41","pubTimestamp":1757338860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 08, 2025 09:41 ET (13:41 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2565873186","title":"CG Oncology Stock Signals Bullish Momentum Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2565873186","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565873186?lang=en_us&edition=fundamental","pubTime":"2025-09-08 21:08","pubTimestamp":1757336880,"startTime":"0","endTime":"0","summary":"CG Oncology has entered its Phase 2 of the Adhishthana Cycle, signaling a bullish setup. With momentum already building, here's what to track...","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/08/CG-Oncology-Adhishthana.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/08/CG-Oncology-Adhishthana.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/09/47546033/cg-oncology-stock-signals-bullish-momentum-ahead","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/09/47546033/cg-oncology-stock-signals-bullish-momentum-ahead","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["CG","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","BK4135","IE00BGHQF748.EUR","CGON","BK4139"],"gpt_icon":1},{"id":"2565895746","title":"JonesTrading Initiates CG Oncology at Buy With $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2565895746","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565895746?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:09","pubTimestamp":1757333378,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has an average rating of buy and mean price target of $59.90, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2565560119","title":"CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2565560119","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565560119?lang=en_us&edition=fundamental","pubTime":"2025-09-06 02:40","pubTimestamp":1757097600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 05, 2025 14:40 ET (18:40 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","CG"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":61,"code":"91000000","status":"200"}]}}